Matteo P.
- Country
- Italy
- Department
- Neurology
Research Overview
- Efficacy and Safety Evaluation of Lecanemab in Early Alzheimer's Disease: A Placebo-Controlled, Double-Blind, Parallel-Group Study with Open-Label Extension
- Efficacy and Safety Evaluation of GSK4527226 in Early Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study
- Long-term Safety and Efficacy Evaluation of GSK4527226 in Early Alzheimer's Disease: An Open-Label Extension Study
Data & Insights
Has run more than one trial at 89 of 126 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in studying early-stage Alzheimer's disease and its progression, with particular attention to therapeutic interventions for cognitive decline.
- Early Alzheimer's Disease Management
- Cognitive Function Assessment
- Disease Progression Monitoring
Their research encompasses evaluation of novel therapeutic approaches for managing mild cognitive impairment in early-stage Alzheimer's patients.
Clinical Assessment
The investigator focuses on implementing Clinical Dementia Rating methodologies, particularly utilizing the Sum of Boxes (CDR-SB) scale for measuring therapeutic outcomes.
- Cognitive Assessment Tools
- Clinical Efficacy Evaluation
- Long-term Treatment Effects
Their expertise includes comprehensive assessment of cognitive and functional outcomes in neurodegenerative conditions.
Therapeutic Innovation
The investigator is involved in evaluating novel therapeutic agents for mild Alzheimer's disease dementia, focusing on disease-modifying approaches.
- Treatment Safety Assessment
- Long-term Efficacy Studies
- Therapeutic Response Monitoring
Their work includes investigating sustained therapeutic effects in neurodegenerative disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.